|
|
Volumn 39, Issue 12, 2001, Pages 529-533
|
|
Montelukast and improvement of eczema: Observations from a prescription event monitoring study in England
a
|
|
Author keywords
Beneficial effects; Eczema; Event monitoring; Prescription; Urticaria
|
|
Indexed keywords
AMINOPHYLLINE;
ANTIALLERGIC AGENT;
ANTIHISTAMINIC AGENT;
BECLOMETASONE;
BUDESONIDE;
CAPTOPRIL;
CEFALEXIN;
CETRIZINE;
CHLORPHENIRAMINE;
CYSTEINYL RECEPTOR ANTAGONIST;
DEXTROPROPOXYPHENE PLUS PARACETAMOL;
DILTIAZEM;
ENALAPRIL;
FEXOFENADINE;
FLUOXETINE;
FLUTICASONE;
FORMOTEROL;
IPRATROPIUM BROMIDE;
LANSOPRAZOLE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LORATADINE;
MONTELUKAST;
PAROXETINE;
PREDNISOLONE;
PROPIONIC ACID;
SALMETEROL;
SIMVASTATIN;
TENAZEPAM;
THEOPHYLLINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL OBSERVATION;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SAFETY;
ECZEMA;
FEMALE;
GENERAL PRACTITIONER;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL INFORMATION;
MONITORING;
PRESCRIPTION;
QUESTIONNAIRE;
SIDE EFFECT;
UNITED KINGDOM;
URTICARIA;
|
|
EID: 0035198498
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP39529 Document Type: Article |
|
Times cited : (7)
|
|
References (7)
|
